The marketing attribution framework we install for every client for healthcare and life sciences in North America
A repeatable, seven-part framework for running marketing attribution as a system — the same one we use inside every Growth Broker engagement. Written for commercial leaders at healthtech, medtech, and life-sciences companies in North America.
This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in North America. In this market, the North American B2B buyer is saturated with vendor outreach and rewards specificity, category clarity, and speed, so the way you install marketing attribution has to be shaped to that reality from day one.
We have installed marketing attribution inside more than fifty companies. This is the framework we reach for every time. Marketing attribution is the honest answer to which activities create pipeline, and the framework exists to keep that definition honest under real conditions.
Part one, diagnosis. Before you touch the model, name the constraint: finance, demand, access, or conversion. Marketing attribution applied to the wrong constraint is theatre.
Part two, target. Narrow to one industry, one role, one trigger. Every extra dimension halves conversion.
Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in North America it is compounded by the fact that signal above noise, not lead volume is what actually gates growth. Marketing attribution is only useful here when it is pointed at both constraints at once.
Part three, offer. What is the buyer's next step, and what makes it obvious? The offer, not the copy, is what carries.
Part four, engine. Tools, sequences, data. Buy the minimum you can operate; every extra tool is a future dependency.
Part five, operating rhythm. Monday plan, Friday review, weekly attribution model reconciled to closed-won. Nothing about the model is left to memory.
Parts six and seven, learning and allocation. What did we learn last week; where does next week's dollar go. Once those two loops are live, marketing attribution compounds and the framework stops being visible.
Concretely for healthcare and life sciences in North America: the healthcare teams that install this get past procurement instead of dying in it, and the North American teams that install this land inside the first quarter, not the fourth. That is the reason it is worth installing marketing attribution deliberately for this market rather than importing a playbook designed for somewhere else.
Frequently asked questions
Measurement · healthcare · North America — answered
- Does marketing attribution work for healthcare and life sciences in North America?
- Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in North America, the North American B2B buyer is saturated with vendor outreach and rewards specificity, category clarity, and speed. The healthcare teams that install this get past procurement instead of dying in it.
- Do I need all seven parts to see results?
- Diagnosis, target, and operating rhythm are the non-negotiables. The others can lag by weeks, not quarters.
- How long does the framework take to install?
- Six to twelve weeks depending on the state of the data and the size of the team.
- Can I adapt the framework to my stack?
- The framework is stack-agnostic. Tooling is part four and is the most swappable piece.
- What is the biggest risk to the framework?
- Picking a model to defend a budget instead of to learn — usually because a stakeholder shortcuts diagnosis to get to spend.
- What is the North America-specific pitfall when running marketing attribution for healthcare?
- Importing a playbook that was built for another market. In North America, the North American B2B buyer is saturated with vendor outreach and rewards specificity, category clarity, and speed — the install has to reflect that.
Growth Broker editorial
Filed under measurement · healthcare · north america